The I4ID2020 edition will largely address the current COVID-19 pandemics as well as other infectious diseases. The Scientific Committee has set-up a stimulating program focusing on Detection, Diagnosis, Clinical Trials immunotherapies and Innovative therapeutic approaches to prevent & fight infectious diseases.
Dr Joachim Confais, Cynbiose & Cynbiose Respiratory’s CSO, will give a talk during the pitch session dedicated to “New approaches to fighting SARS-CoV-2″ on December 9th, 2020.
The oral presentation entitled “African Green Monkey model of SARS-CoV-2 infection shows mild lung pathology and viral replication in the airways” will unveil the results of the non-human primate efficacy model developed in collaboration with the VirPath academic laboratory.
Cynbiose and Cynbiose Respiratory teams will be pleased to meet you during this event and discuss on how clinically relevant NHP models could foster the preclinical development of your vaccines or immunotherapies.
Please contact us to learn more on our infectious and respiratory diseases models including the SARS-CoV-2 NHP models.
More information on I4ID congress.
